Intersect ENT, based in Palo Alto, CA, is a leading provider of integrated technologies for the treatment of chronic rhinosinusitis, offering less invasive and cost-effective solutions to improve patient care.
The company specializes in the development and distribution of innovative implants and delivery systems, such as PROPEL and SINUVA, which are designed to alleviate symptoms and enhance treatment outcomes. With a commitment to transforming patient care, Intersect ENT continues to advance the field of rhinosinusitis treatment through its patented technologies and comprehensive product portfolio.
Generated from the website